Gene · 55669
Papers3,795
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,795
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long-term iron supplementation combined with vitamin B6 enhances maximal oxygen uptake and promotes skeletal muscle-specific mitochondrial biogenesis in rats. | Front Nutr | 2023 | 38288063 | PubTator, text mining | PubMed |
| Mitochondria in Multi-Directional Differentiation of Dental-Derived Mesenchymal Stem Cells. | Biomolecules | 2023 | 38275753 | PubTator, text mining | PubMed |
| DEK deficiency suppresses mitophagy to protect against house dust mite-induced asthma. | Front Immunol | 2023 | 38274803 | PubTator, text mining | PubMed |
| Metabolic control of induced pluripotency. | Front Cell Dev Biol | 2023 | 38274274 | PubTator, text mining | PubMed |
| Post-translational modification and mitochondrial function in Parkinson's disease. | Front Mol Neurosci | 2023 | 38273938 | PubTator, text mining | PubMed |
| The potential influence of melatonin on mitochondrial quality control: a review. | Front Pharmacol | 2023 | 38273825 | PubTator, text mining | PubMed |
| Characteristics of elderly diabetes patients: focus on clinical manifestation, pathogenic mechanism, and the role of traditional Chinese medicine. | Front Pharmacol | 2023 | 38273819 | PubTator, text mining | PubMed |
| The role of non-coding RNAs in muscle aging: regulatory mechanisms and therapeutic potential. | Front Mol Biosci | 2023 | 38264571 | PubTator, text mining | PubMed |
| Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 38205213 | PubTator, text mining | PubMed |
| Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications. | Int J Mol Sci | 2023 | 38203521 | PubTator, text mining | PubMed |
| Dose-Dependent Effects of Radiation on Mitochondrial Morphology and Clonogenic Cell Survival in Human Microvascular Endothelial Cells. | Cells | 2023 | 38201243 | PubTator, text mining | PubMed |
| Selective inhibitors targeting Fis1/Mid51 protein-protein interactions protect against hypoxia-induced damage in cardiomyocytes. | Front Pharmacol | 2023 | 38192411 | PubTator, text mining | PubMed |
| Mitochondrial transplantation: the advance to therapeutic application and molecular modulation. | Front Cardiovasc Med | 2023 | 38162128 | PubTator, text mining | PubMed |
| The role of mitochondrial dynamics in disease. | MedComm (2020) | 2023 | 38156294 | PubTator, text mining | PubMed |
| Novel Relationship between Mitofusin 2-Mediated Mitochondrial Hyperfusion, Metabolic Remodeling, and Glycolysis in Pulmonary Arterial Endothelial Cells. | Int J Mol Sci | 2023 | 38139362 | PubTator, text mining | PubMed |
| An Update on Protein Kinases as Therapeutic Targets-Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein-Protein Interactions. | Int J Mol Sci | 2023 | 38139336 | PubTator, text mining | PubMed |
| Hexavalent-Chromium-Induced Disruption of Mitochondrial Dynamics and Apoptosis in the Liver via the AMPK-PGC-1α Pathway in Ducks. | Int J Mol Sci | 2023 | 38139070 | PubTator, text mining | PubMed |
| C-Type Natriuretic Peptide Pre-Treatment Improves Maturation Rate of Goat Oocytes by Maintaining Transzonal Projections, Spindle Morphology, and Mitochondrial Function. | Animals (Basel) | 2023 | 38136917 | PubTator, text mining | PubMed |
| Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases. | Biomolecules | 2023 | 38136659 | PubTator, text mining | PubMed |
| Actin Polymerization Defects Induce Mitochondrial Dysfunction in Cellular Models of Nemaline Myopathies. | Antioxidants (Basel) | 2023 | 38136143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55669/papers?page=17